Main > ONCOLOGY (**) > Breast Cancer>ER->HER2->PR-> > TREAT.: > USA. G. AtezolizuMAb+CT

---

USA. G. AtezolizuMAb+CT's subsections
(*) USA Approval Date: 2019. 03.08.
>METASTATIC>PD-L1+
Companion Diagnostic Test>
Company
CT: PacliTaxel-Albumin Particles>
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2019. 03.05.
TradeMark
TradeMark Web-Site

USA. G. AtezolizuMAb+CT's products
This section has no products